Highmark Health, Spring Health Team Up for Mental Health Solution
Spring Health and Highmark Health are collaborating to launch Mental Well-Being, a solution that offers therapy, medication and other services for some Highmark members.
Spring Health and Highmark Health are collaborating to launch Mental Well-Being, a solution that offers therapy, medication and other services for some Highmark members.
Spring Health launched Sage, a platform that offers asynchronous video lessons to help employees manage their own mental health and support managers in creating a healthy work environment.
Spring Health's Family Care solution now serves kids of all ages and their parents. It connects each family with a care navigator and offers a dashboard that allows parents and caregivers to track their child's care.
The peer-reviewed research is among the first to examine the effectiveness of the new crop of digital mental health startups. It looked at people enrolled through their companies in a mental health platform developed by Spring Health.
The company, which offers mental health solutions for employers and health plans, recently closed a $190 million series C round, that included both equity and debt. It also brought on Guardian Life as a strategic investor.
Spring Health, a startup that offers mental health services as an employee benefit, raised $75 million in funding. The New York-based startup matches employees with therapy and other mental health services.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The news follows a deal announced last month between Lantern and chronic disease management company Omada Health to add the company's CBT-based therapies to launch new programs for depression and anxiety.
The William K. Warren Foundation co-led the round with angel investor Kevin Ryan.